Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0Q9WO
|
|||
Former ID |
DAP001250
|
|||
Drug Name |
Cinolazepam
|
|||
Synonyms |
Cinolazepamum; Gerodorm; Cinolazepam [INN]; OX 373; Cinolazepam (INN); Cinolazepamum [INN-Latin]; Gerodorm (TN); OX-373;1-(2-cyanoethyl)-7-chloro-3-hydroxy-5-(2'-fluorophenyl)-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-2,3-dihydro-1H-1,4-benzodiazepin-1-yl]propanenitrile; 3-[7-chloro-5-(2-fluorophenyl)-3-hydroxy-2-oxo-3H-1,4-benzodiazepin-1-yl]propanenitrile; 7-Chloro-5-(o-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propionitrile; 7-chloro-5-(2-fluorophenyl)-2,3-dihydro-3-hydroxy-2-oxo-1H-1,4-benzodiazepine-1-propanenitrile
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Muscle spasm [ICD-11: MB47.3] | Approved | [1] | |
Therapeutic Class |
Anticonvulsants
|
|||
Structure |
Download2D MOL |
|||
Formula |
C18H13ClFN3O2
|
|||
Canonical SMILES |
C1=CC=C(C(=C1)C2=NC(C(=O)N(C3=C2C=C(C=C3)Cl)CCC#N)O)F
|
|||
InChI |
1S/C18H13ClFN3O2/c19-11-6-7-15-13(10-11)16(12-4-1-2-5-14(12)20)22-17(24)18(25)23(15)9-3-8-21/h1-2,4-7,10,17,24H,3,9H2
|
|||
InChIKey |
XAXMYHMKTCNRRZ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 75696-02-5
|
|||
PubChem Compound ID | ||||
PubChem Substance ID | ||||
ChEBI ID |
CHEBI:59514
|
|||
SuperDrug ATC ID |
N05CD13
|
|||
SuperDrug CAS ID |
cas=075696025
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Translocator protein (TSPO) | Target Info | Binder | [2] |
KEGG Pathway | Neuroactive ligand-receptor interaction | |||
HTLV-I infection |
References | Top | |||
---|---|---|---|---|
REF 1 | Drug information of Cinolazepam, 2008. eduDrugs. | |||
REF 2 | Short-term sleep laboratory studies with cinolazepam in situational insomnia induced by traffic noise. Int J Clin Pharmacol Res. 1987;7(5):407-18. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.